Dog Parvovirus: Prevention Through Vaccination

Canine parvovirus causes severe hemorrhagic gastroenteritis, particularly in puppies. Vaccination is almost entirely effective and represents a major welfare advance.

Key Facts

Parvovirus (CPV-2) is an extremely resistant virus that can survive in soil for months to years
It causes severe vomiting, bloody diarrhea, and immune suppression — mortality without treatment reaches 80-90%
Puppies aged 6-20 weeks are most vulnerable due to declining maternal antibody protection
Vaccination with modified live vaccine provides excellent, durable protection from 16 weeks
Supportive treatment (IV fluids, anti-nausea, antibiotics for secondary infection) reduces mortality to 5-20%
Outbreaks occur in unvaccinated populations, rescue shelter intakes, and areas with low vaccination rates

Welfare Considerations

Parvoviral disease causes extreme suffering — profuse vomiting, severe hemorrhagic diarrhea, intense nausea, and immune collapse that allows secondary bacterial sepsis. Puppies deteriorate rapidly and the disease progression is distressing to witness. The acute welfare harm of parvovirus is almost entirely preventable through standard vaccination. Parvovirus outbreaks in unvaccinated communities represent concentrated, preventable suffering on a significant scale. Veterinary care for confirmed cases requires intensive hospitalization; home treatment is associated with substantially higher mortality.

What You Can Do

Vaccinate puppies starting at 8 weeks with a core vaccine series completed by 16 weeks
Keep unvaccinated puppies away from high-risk environments (dog parks, pet stores, shelters) until fully protected
Maintain adult booster vaccinations as recommended by your vet — protection duration varies by individual
Support low-cost vaccination clinics in communities with lower vaccination rates to prevent outbreaks